| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.41 | 0.0007 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |